Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0LYXMN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
h1H6958N2-N297Q-Ex20
|
|||||
| Synonyms |
H1H6958N2-N297Q-Ex20
Click to Show/Hide
|
|||||
| Organization |
Regeneron Pharmaceuticals Inc
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.7
|
|||||
| Structure |
|
|||||
| Antibody Name |
H1H6958N2
|
Antibody Info | Antigen Name |
Undisclosed
|
||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
Ex20
|
|||||